StockNews.com Begins Coverage on Akari Therapeutics (NASDAQ:AKTX)
Equities research analysts at StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Free Report) in a research note issued on Tuesday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Akari Therapeutics Trading Up 11.9% NASDAQ AKTX opened at $1.41 on Tuesday. Akari Therapeutics has a 12 month low of […]
Equities research analysts at StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Free Report) in a research note issued on Tuesday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Akari Therapeutics Trading Up 11.9% NASDAQ AKTX opened at $1.41 on Tuesday. Akari Therapeutics has a 12 month low of […]
